Critical Care Medicine Doctors in Manhasset, NY Accepting Medicare

5 Critical Care Medicine doctors found. Showing 1 - 5

Dr. Gioiamaria B Berna, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Community Dr, Manhasset, NY 11030 Phone: 516-562-2308

Dr. Hugh Albert Cassiere, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Community Dr, Manhasset, NY 11030 Phone: 516-562-2294    Fax: 516-562-1226

Kimberly Clark, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: Nsuh-dept Of Medicine, 300 Community Drive, Manhasset, NY 11030 Phone: 516-562-4970

Sameer Khanijo, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Community Dr, Manhasset, NY 11030 Phone: 516-562-0100

Dr. Kaitlin Seitz, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1155 Northern Blvd # 3000, Manhasset, NY 11030 Phone: 516-407-4000    Fax: 212-731-5210

News Archive

Natco Pharma submits ANDA to FDA for generic version of Tamiflu 75 mg capsules

Gilead Sciences, today announced receipt of a Paragraph IV Certification Notice Letter advising that Natco Pharma Limited submitted an Abbreviated New Drug Application to the U.S. Food and Drug Administration requesting permission to manufacture and market a generic version of Tamiflu 75 mg capsules.

Chemo boosts survival rates for pancreatic cancer

The use of chemotherapy following surgery reduces the risk of death from operable pancreatic cancer by around 30 per cent, says new research published in the British Journal of Cancer.

Lymphocyte count serves as simple and effective prognostic indicator in renal cell carcinoma

Each year, kidney cancer is diagnosed in nearly 60,000 people in the U.S. Many of these patients undergo surgery to remove the affected kidney, but this procedure can be risky for the elderly and those who have other health problems. Unfortunately, the prognosis of kidney cancer patients often cannot be determined until tumor samples are surgically removed and evaluated.

Researchers discover origin of resistance to lung cancer

For treating cancer, drugs based on molecules known as tyrosine kinase inhibitors are sometimes used. One such tyrosine kinase inhibitor, called osimertinib, has been used to treat EGFR-mutated lung cancer with a certain degree of efficacy.

Titan Pharmaceuticals expects approximately $1.6M as royalty on first-quarter sales of Fanapt

Titan Pharmaceuticals, Inc. today confirmed that the company expects to receive a payment of approximately $1.6 million by May 15, 2010 as the royalty on the first quarter 2010 sales of Fanapt™ (iloperidone), a drug for the treatment of schizophrenia launched in the US by Novartis Pharma AG in January 2010.

Read more Medical News

› Verified 6 days ago